News

Researchers See Silver Lining in Anti-HIV Gel's Failure


 

from the lancet

Dr. McCormack’s study was funded by the U.K. government, the European and Developing Countries Clinical Trials Partnership, the International Partnership for Microbicides, and Endo Pharmaceuticals, the manufacturer of PRO2000, which donated the gels for the study. One coauthor of the study was an employee of Endo Pharmaceuticals with an equity interest in the company.

Pages

Recommended Reading

Ceftaroline Data Robust Even Under New Antibiotic Efficacy Standards, FDA Says
MDedge Internal Medicine
Severity of 2009 H1N1 Infection Found Similar to Previous Years’ Infections
MDedge Internal Medicine
FDA Panel Supports IV Antibiotic for Skin and Skin Structure Infections
MDedge Internal Medicine
Only 2% of U.S. Hospitals Engaged in “Meaningful Use” of EHRs
MDedge Internal Medicine
Prophylactic Antiviral Treatment May Decrease Ocular Herpes Recurrences
MDedge Internal Medicine
Rise in E. coli Infections Challenges Empiric Therapy
MDedge Internal Medicine
Long-Term Care, Previous Antibiotics Linked to Drug-Resistant P. mirabilis
MDedge Internal Medicine
Investigational Fidaxomicin Tops Vancomycin for Recurrent C. Difficile Infection
MDedge Internal Medicine
Timing, Type of anti-TNFa Therapy Linked to L. Pneumophila
MDedge Internal Medicine
Hearing Loss in Pneumococcal Meningitis Linked to Otitis, Serotype 9V Infection
MDedge Internal Medicine